David Altshuler
EVP, Chief Scientific Officer · 1 filing · Latest: Jan 22, 2026
VERTEX PHARMACEUTICALS INC / MA
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VRTX | ALTSHULER DAVID | — | May 15, 2025 | Proposed Sale | $424.69 | 52 | $22.1K | — | |
VRTX | ALTSHULER DAVID | — | Mar 13, 2025 | Proposed Sale | $510.00 | 3,231 | $1.6M | — | |
VRTX | ALTSHULER DAVID | — | Mar 10, 2025 | Proposed Sale | $500.00 | 3,231 | $1.6M | — | |
VRTX | ALTSHULER DAVID | — | Mar 3, 2025 | Proposed Sale | $490.00 | 3,231 | $1.6M | — | |
VRTX | ALTSHULER DAVID | — | Feb 27, 2025 | Proposed Sale | $480.00 | 1,272 | $610.6K | — | |
VRTX | ALTSHULER DAVID | — | Feb 25, 2025 | Proposed Sale | $480.95 | 848 | $407.8K | — | |
VRTX | ALTSHULER DAVID | — | Feb 20, 2025 | Proposed Sale | $480.00 | 1,111 | $533.3K | — | |
VRTX | ALTSHULER DAVID | — | Nov 15, 2024 | Proposed Sale | $478.56 | 15 | $7.2K | — |